127 studies found for:    Open Studies | "Migraine Disorders"
Show Display Options
Rank Status Study
21 Unknown  Study With Amitriptylin to Evaluate the Efficacy of Melatonin in Treatment of Migraine
Condition: Migraine
Interventions: Drug: Amitriptyline;   Drug: Melatonin;   Drug: Placebo
22 Recruiting The Effect of Histamine H1 Receptor Antagonist, Clemastin, on PACAP38 Induced Headache in Migraine Patients
Condition: Migraine Without Aura
Intervention: Drug: PACAP38
23 Recruiting Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine
Condition: Episodic Migraine
Intervention: Drug: Dextromethorphan and quinidine
24 Unknown  Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives.
Conditions: Menstrual Migraines;   Menstrual Bleeding;   Menstrual Spotting
Intervention: Drug: Estradiol or Placebo
25 Recruiting TI-001 (Intranasal Oxytocin) for Treatment of Chronic Migraine
Condition: Chronic Migraine
Interventions: Drug: TI-001;   Drug: Placebo
26 Not yet recruiting Intranasal Cooling for Symptomatic Relief of Migraine
Condition: Migraine Headache
Interventions: Device: Active RhinoChill;   Device: Placebo RhinoChill
27 Unknown  Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache
Condition: Migraine Headache
Intervention: Drug: Octreotide
28 Recruiting A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache
Condition: Migraine Headache, Episodic
Intervention: Device: neuromodulation for episodic migraine headache
29 Unknown  Double-blind Randomized Clinical Trial of Transcranial Magnetic Stimulation in Chronic Migraine
Condition: Chronic Migraine
Interventions: Device: 10Hz active rTMS;   Device: Placebo
30 Unknown  Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches
Condition: Refractory Migraine
Intervention: Drug: Botulinum toxin A
31 Not yet recruiting ASIS for Botox in Chronic Migraine
Condition: Chronic Migraine More than15 Days Per Month, and Lasting 4 Hours a Day or Longer.
Interventions: Drug: Gadolinium;   Drug: Efficacy of Botox intramuscularly at Week 6;   Drug: Efficacy of Botox intramuscularly at Week 12;   Drug: Efficacy of Botox intramuscularly at Week 18;   Drug: Efficacy of Botox intramuscularly at Week 24,;   Drug: Efficacy of Botox intramuscularly at Week 30;   Drug: Efficacy of Botox subdermally at Week 6;   Drug: Efficacy of Botox subdermally at Week 12;   Drug: Efficacy of Botox subdermally at Week 18;   Drug: Efficacy of Botox subdermally at Week 24;   Drug: Efficacy of Botox subdermally at Week 30;   Drug: Adverse Reactions of Botox intramuscularly;   Drug: Adverse Reactions of Botox subdermally
32 Recruiting Evaluation of the Prophylactic Efficacy of tDCS in Chronic Migraine
Condition: Chronic Migraine as Defined by Criteria of International Headache Society (IHS)
Interventions: Device: Transcranial direct current stimulation of the motor cortex;   Device: simulation of Transcranial direct current stimulation of the motor cortex
33 Recruiting A Study to Evaluate the Efficacy and Safety of AMG 334 in Chronic Migraine Prevention
Condition: Treatment for Prevention of Chronic Migraine
Interventions: Drug: AMG 334;   Drug: Placebo
34 Recruiting A Safety and Efficacy Study of BOTOX® in Korean Adults With Chronic Migraine
Condition: Migraine Disorders
Intervention: Biological: botulinum toxin Type A
35 Recruiting Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Chronic Migraine in Korea
Conditions: Migraine Disorders;   Headache
Intervention: Biological: botulinum toxin Type A
36 Recruiting A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
Condition: Migraine Disorders
Interventions: Biological: Botulinum toxin type A Dose 1;   Biological: Botulinum toxin type A Dose 2;   Drug: Placebo (Normal Saline)
37 Recruiting Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults
Condition: Migraine Disorders
Interventions: Biological: onabotulinumtoxinA;   Drug: Topiramate
38 Unknown  Treximet in Acute Migraine Headache: Assessing Cognitive Function
Conditions: Migraine Headache;   Cognitive Impairment
Interventions: Drug: Treximet;   Drug: Migraine rescue medication of choice
39 Recruiting Occipital Transcutaneous Stimulation in Chronic Migraine
Condition: Chronic Migraine
Intervention: Device: Cefaly Kit Arnold
40 Recruiting RCT Versus Placebo of rTMSQP Over Visual Cortex for the Prevention of Chronic Migraine
Condition: Chronic Migraine
Intervention: Device: Super Rapid Magstim Stimulator

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years